Previous Page  19 / 30 Next Page
Information
Show Menu
Previous Page 19 / 30 Next Page
Page Background

Page 76

conferenceseries

.com

Volume 3

Diagnostic Pathology: Open Access

ISSN: 2476-2024

Laboratory Medicine 2018

June 25-26, 2018

June 25-26, 2018 | Berlin, Germany

13

th

International Conference on

Laboratory Medicine & Pathology

Second opinion in pathology: Still Not Automated. Evidence Pro and Evidence Against

Nickolas Myles

University of British Columbia, Canada

T

he objective of our study is to: 1. distinguish between error and opinion; contrast accuracy and precision in pathology

in respect to second review process. 2. Critically appraise and grade (Oxford system) core recent examples of published

evidence in support and against second reviews in pathology. 3. Contrast second opinion which is actively sought and “reflex”

second reviews (i.e. “node negative breast cancer etc.). 3. Apply AGREE tool for critical appraisal of guidelines to determine

the strength of the recommendations for second reviews in pathology. 4. Determine the efficient strategy to reduce diagnostic

discrepancies resulted after second reviews in pathology. We have conducted two comprehensive searches PUBMED using the

keywords: “2

nd

opinion, pathology”: 4214 references and “2

nd

opinion, pathology, outcomes: 727”. Of them, we further extracted

41 studies which contained numeric information on agreement, major and minor disagreement and whether pathology second

opinion change outcomes and/or patient management. The following were observed: 1. we identified several trends in the

extracted evidence: 2. lower discrepancy if one institution reviews itself; cases include full spectrum daily pathology; cases

when pathologists actively seek 2nd opinion excluded (i.e. I am uncertain and asking for help, so I refer the case, having no firm

diagnosis in the first place). 3. higher discrepancy if single institution reviews external cases; referred rather than population

based (referral bias due to higher complexity); additional tests performed/ new information given to 2nd pathologist (not

available to 1st pathologist); cases when 1st pathologist was uncertain (and thus referred) included with the others. Despite the

relatively common disagreement between the pathologist, the information whether such disagreements affect patient outcomes

is lacking. We present out data in an organized fashion as for the whole spectrum pathology, as by pathology subspecialty areas.

nmyles@providnecehealth.bc.ca

Diagn Pathol Open 2018, Volume 3

DOI: 10.4172/2476-2024-C1-003